Clinical Trials at Montefiore Nyack Hospital

Clinical trials are medical research studies that look for new ways to prevent, detect or treat disease. There are many kinds of clinical trials. Some test new drugs, while others look at new surgical procedures or devices, or new ways to use current treatments.

People who participate in a clinical trial can contribute to finding new treatments and cures for diseases. If you participate, you will be helping others in the future, but you might receive a novel treatment, and you will have extra care and attention from the medical research staff.

At Montefiore Nyack Hospital, patients who choose to participate in a cancer clinical trial receive comprehensive, advanced care, sometimes well before it is available anywhere else.

For frequently asked questions, click here >

A Randomize Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 negative Breast Cancer.
(Alliance)

Jun 25, 2019 - A Phase III Double-blind Randomised Study Assessing the Efficacy and Safety of Capivasertib + Paclitaxel Versus Placebo +...

MammaPrint, BluePrint and Full –Genome Data Linked with Clinical Data to Evaluate New Gene Expression Profiles. An Adaptable Registry.

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Pembrolizumab plus Chemo vs Placebo plus Chemo for the treatment of Chemotherapy...

Prospective Evaluation of Carvediol in Prevention of Cardiac Toxicity in Patients with Metastatic HER 2+ Breast Cancer.
(SWOG)

A Phase III, Randomized, Double- Blind, Placebo-Controlled, Multicenter study to evaluate the Efficacy and Safety of Anamorelin HCL for the...

A study that will accrue patients that are potentially eligible for the Adjuvant treatment studies and perform molecular Testing.

Integration of Immunotherapy into Adjuvant therapy for Resected Non-Small Cell Lung Cancer.

A Phase 1b/ 3 double – blind, randomized active controlled 3- stage, Biomarker, adaptive study of Tazemetostat or Placebo in combination with...

Collection of Blood, Urine, and Tissue samples from patients with Solid Malignant Tumors.